Skip to main navigation
Skip to search
Skip to main content
The Aga Khan University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Tocilizumab in patients hospitalized with Covid-19 pneumonia
Carlos Salama
, Jian Han
, Linda Yau
, William G. Reiss
, Benjamin Kramer
, Jeffrey D. Neidhart
, Gerard J. Criner
, Emma Kaplan-Lewis
, Rachel Baden
, Lavannya Pandit
, Miriam L. Cameron
, Julia Garcia-Diaz
, Victoria Chávez
, Martha Mekebeb-Reuter
, Ferdinando Lima De Menezes
,
Reena Shah
, Maria F. González-Lara
, Beverly Assman
, Jamie Freedman
, Shalini V. Mohan
Medical College, East Africa
Research output
:
Contribution to journal
›
Article
›
peer-review
1021
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tocilizumab in patients hospitalized with Covid-19 pneumonia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
COVID-19
100%
Tocilizumab
100%
Artificial Respiration
66%
Placebo
66%
Hazard Ratio
22%
Adverse Event
11%
Body Weight
11%
Intention-to-Treat Analysis
11%
Ethnic Groups
11%
Receptor Antibody
11%
Log Rank Test
11%
Interleukin 6 Receptor
11%
Lanoteplase
11%
Primary Outcome
11%
Pharmacology, Toxicology and Pharmaceutical Science
Coronavirinae
100%
Tocilizumab
100%
Diseases
100%
Placebo
66%
Adverse Event
11%
Interleukin 6 Receptor
11%
Receptor Antibody
11%
Lanoteplase
11%